{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:43Z","timestamp":1791235303055,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Qatar National Library"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bcp.2020.114217","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T23:42:38Z","timestamp":1599867758000},"page":"114217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism"],"prefix":"10.1016","volume":"182","author":[{"given":"Eleftheria","family":"Lefkou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-4384","authenticated-orcid":false,"given":"Katerina","family":"Varoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Pombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9540-7123","authenticated-orcid":false,"given":"Aleksandar","family":"Jurisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaklina","family":"Jurisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Contento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114217_b0005","doi-asserted-by":"crossref","unstructured":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Lancet. 2016, 387 (10017), 462-74.","DOI":"10.1016\/S0140-6736(15)00838-7"},{"key":"10.1016\/j.bcp.2020.114217_b0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","article-title":"Cardiovascular System in Preeclampsia and Beyond","volume":"73","author":"Thilaganathan","year":"2019","journal-title":"Hypertension."},{"issue":"6","key":"10.1016\/j.bcp.2020.114217_b0015","first-page":"1108","article-title":"The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction","volume":"78","author":"Polzin","year":"1991","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114217_b0020","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0b013e3181fe02ec","article-title":"Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis","volume":"116","author":"do Prado","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114217_b0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2011.02.006","article-title":"The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis","volume":"128","author":"Abou-Nassar","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2020.114217_b0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","article-title":"Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome","volume":"75","author":"Bertolaccini","year":"2016","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.bcp.2020.114217_b0035","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mp.2014.110","article-title":"Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)\u2013conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development","volume":"20","author":"Girardi","year":"2015","journal-title":"Mol. Psychiatry."},{"issue":"3","key":"10.1016\/j.bcp.2020.114217_b0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2020.114217_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114217_b0050","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience","volume":"80","author":"Branch","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.bcp.2020.114217_b0055","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2020.114217_b0060","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","article-title":"Role of complement component C1q in the onset of preeclampsia in mice","volume":"58","author":"Singh","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2020.114217_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2020.114217_b0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.bcp.2020.114217_b0075","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1161\/HYPERTENSIONAHA.114.03115","article-title":"Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin","volume":"63","author":"Lefkou","year":"2014","journal-title":"Hypertension."},{"issue":"8","key":"10.1016\/j.bcp.2020.114217_b0080","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2020.114217_b0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bcp.2020.114217_b0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114217_b0095","first-page":"506","article-title":"The fetal safety of statins: a systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"J. Obstet. Gynecol. Cam."},{"issue":"5","key":"10.1016\/j.bcp.2020.114217_b0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bcp.2020.114217_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bcp.2020.114217_b0110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"StAmP trial collaborative group. Pravastatin for early-onset preeclampsia: a randomized, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.bcp.2020.114217_b0115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.placenta.2013.05.002","article-title":"The transfer of pravastatin in the dually perfused human placenta","volume":"34","author":"Zarek","year":"2013","journal-title":"Placenta."},{"issue":"42","key":"10.1016\/j.bcp.2020.114217_b0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"7","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bcp.2020.114217_b0125","first-page":"285","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"2","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"9751","key":"10.1016\/j.bcp.2020.114217_b0130","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"issue":"113","key":"10.1016\/j.bcp.2020.114217_b0135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"5","author":"Giannakopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2020.114217_b0140","unstructured":"Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 2013;122(5):1122\u20131131."},{"issue":"5","key":"10.1016\/j.bcp.2020.114217_b0145","first-page":"624","article-title":"Fetal growth and perinatal viability in California","volume":"59","author":"Williams","year":"1982","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.bcp.2020.114217_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013663","article-title":"A new mouse model to explore therapies for preeclampsia","volume":"5","author":"Ahmed","year":"2010","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2020.114217_b0155","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/260617a0","article-title":"Mechanical properties of vascular smooth muscle cells in situ","volume":"260","author":"Mulvany","year":"1976","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2020.114217_b0160","doi-asserted-by":"crossref","first-page":"H1845","DOI":"10.1152\/ajpheart.1998.275.5.H1845","article-title":"Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase","volume":"275","author":"Vagnoni","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2020.114217_b0165","doi-asserted-by":"crossref","first-page":"H1730","DOI":"10.1152\/ajpheart.1997.272.4.H1730","article-title":"Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression","volume":"272","author":"Magness","year":"1997","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"17","key":"10.1016\/j.bcp.2020.114217_b0170","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2008-12-194258","article-title":"Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury","volume":"113","author":"Redecha","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2020.114217_b0175","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"AJOG"},{"key":"10.1016\/j.bcp.2020.114217_b0180","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1191\/096120300677692516","article-title":"Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study","volume":"9","author":"Ames","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.bcp.2020.114217_b0185","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114217_b0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell","volume":"121","author":"Ramesh","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bcp.2020.114217_b0195","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1006\/jmcc.1998.0831","article-title":"Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins","volume":"30","author":"Kouretas","year":"1998","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114217_b0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114217_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cvr\/cvp084","article-title":"Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA\/Rho-kinase activation","volume":"83","author":"Ying","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.114217_b0210","doi-asserted-by":"crossref","first-page":"H1562","DOI":"10.1152\/ajpheart.00241.2007","article-title":"Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging","volume":"294","author":"Bulckaen","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2020.114217_b0215","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2020.114217_b0220","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jri.2013.09.001","article-title":"Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors","volume":"101\u2013102","author":"Staff","year":"2014","journal-title":"J. Reprod. Immunol."},{"issue":"suppl 2","key":"10.1016\/j.bcp.2020.114217_b0225","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1177\/096120339800700218","article-title":"Placental pathology in antiphospholipid syndrome","volume":"7","author":"Levy","year":"1998","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.bcp.2020.114217_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(96)90377-9","article-title":"Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature","volume":"27","author":"Nayar","year":"1996","journal-title":"Hum. Pathol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:12:05Z","timestamp":1762096325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220304536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"alternative-id":["S0006295220304536"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114217","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114217"}}